![]() ![]() Twenty years after the human genome was sequenced, and despite an overwhelming focus on gene-centric research, very little has changed for the cancer patient. Only 6% of cancer drugs approved between 2006–2017 showed meaningful, measurable, quality of life improvements while a good 70% show 0% improvement in survival. Cost of cancer care will consume more than 80% of cancer spending by 2030. She said: "There is a crisis in oncology. I recently spoke with Azra about her plans to establish The First Cell Center for Cancer Survivors (FICCCS), and asked her to provide a summary for us of how it might work. The logical entry point into this path begins with the most important resource now available-extant cancer survivors. In the popular magazine Scientific American, the group recently published their vision for a future when no cancer will be detected too late to treat. ![]() Shortly thereafter, a group of noted dignitaries in the field collectively called The Oncology Think Tank convened to begin hashing out this new imperative, and then bring it to fruition. ![]()
0 Comments
Leave a Reply. |